Back to Search
Start Over
Cardiovascular safety of novel non-small cell lung cancer oncotherapy in a patient treated with novel generations of tyrosine kinase inhibitors.
- Source :
-
Kardiologia polska [Kardiol Pol] 2018; Vol. 76 (3), pp. 670. - Publication Year :
- 2018
- Subjects :
- Acrylamides
Afatinib
Aniline Compounds
Antineoplastic Agents therapeutic use
Carcinoma, Non-Small-Cell Lung secondary
Cardiovascular Diseases chemically induced
Gefitinib
Humans
Lung Neoplasms pathology
Middle Aged
Nebivolol therapeutic use
Piperazines adverse effects
Piperazines therapeutic use
Protein Kinase Inhibitors therapeutic use
Quinazolines adverse effects
Quinazolines therapeutic use
Ramipril therapeutic use
Antineoplastic Agents adverse effects
Carcinoma, Non-Small-Cell Lung drug therapy
Cardiotonic Agents therapeutic use
Cardiovascular Diseases prevention & control
Lung Neoplasms drug therapy
Protein Kinase Inhibitors adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 1897-4279
- Volume :
- 76
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Kardiologia polska
- Publication Type :
- Academic Journal
- Accession number :
- 29558014
- Full Text :
- https://doi.org/10.5603/KP.2018.0061